Shelterin

Subunits

Shelterin has six subunits: TRF1, TRF2, POT1, RAP1, TIN2, and TPP1. They can operate in smaller subsets to regulate the length of or to protect telomeres. In the cells of mice and humans, TRF1, TRF2, TIN2, and RAP1 are about ten times more abundant than TPP1 and POT1.

• TRF1 (Telomere Repeat binding Factor 1): TRF1 is a homodimeric protein that binds to the double-stranded TTAGGG region of the telomere. TRF1 along with TRF2 normally prevents telomerase from adding more telomere units to telomeres. But when telomere lengthening is required, TRF1 recruits helicases and interacts with tankyrases to facilitate the process. TRF1 is highly expressed in stem cells, and is essential for generation of induced pluripotent stem cells. TRF1 is upregulated in the brain cancer glioblastoma multiforme (GBM) in humans and mice, because of the stem-cell quality of the cancer. Genetic ablation and chemical inhibition of TRF1 in mouse models of the brain cancer glioblastoma, and chemical inhibition of cultured human GBM cells inhibited tumor growth. TRF1 levels decrease with aging in humans and in mice. Increasing TRF1 in mice by gene therapy (AAV9 delivery) improved memory and other measures of health span. Conversely, inhibition of the PI3K/AKT pathway decreases TRF1, resulting in telomere-induced DNA damage. TRF1 may recruit PINX1 to inhibit telomere elongation by telomerase.
• TRF2 (Telomere Repeat binding Factor 2) TRF2 is structurally related to TRF1, and helps to form T-loops. TRF2 is a homodimeric protein that binds to the double-stranded TTAGGG region of the telomere and prevents the recognition of double-strand DNA breaks. Overexpression of TRF2 leads to telomere shortening. Loss of TRF2 which leads to loss of the T-loop can activate p53 or ATM-mediated apoptosis.
• Both TRF1 and TRF2 recruit the other four subunits to the telomere. Both TRF1 and TRF2 participate in telomere replication as well as in the prevention of replication fork stalling. Exercise has been shown to upregulate both TRF1 and TRF2 in leukocytes as well as endothelial cells, thereby protecting against apoptosis.
• RAP1 (Repressor / Activator Protein 1): RAP1 is a stabilizing protein associated with TRF2. RAP1 inhibits DNA repair.
• POT1 (Protection of Telomere 1): POT1 contains OB-folds (Oligonucleotide/oligosaccharide Binding) that bind POT1 to single-stranded DNA, which increase its affinity for single-stranded TTAGGG region of telomeric DNA. POT1 helps form the telomere-stabilizing D-loop. POT1 prevents the degradation of this single stranded DNA by nucleases and shelters the 3' G-overhang. POT1 suppresses ATR-mediated DNA repair. Humans only have a single POT1, whereas mice have POT1a and POT1b. POT1a inhibits DNA damage repair at the telomere, whereas POT1b regulates the length of telomeric single-stranded DNA.
• TPP1: TPP1 is a protein associated with POT1, which is encoded by the ACD (gene). The loss of TPP1 leads to impaired POT1 function. When telomeres are to be lengthened, TPP1 is a central factor in recruiting telomerase to telomeres. TPP1 is the only shelterin protein in direct contact with telomerase. TPP1 promotes telomerase processivity in the presence of POT1. But interaction with the CST Complex limits excessive telomere elongation by telomerase. The gene which encodes for TPP1 (ACD) is distinct from the unrelated TPP1 gene on chromosome 11, which encodes tripeptidyl-peptidase I.
• TIN2 (TRF1- and TRF2-Interacting Nuclear Protein 2) TIN2 is a stabilizing protein that binds to TRF1, TRF2, and the TPP1-POT1 complex. thereby bridging units attached to double-stranded DNA and units attached to single-stranded DNA. TIN2 seems to affect telomerase activity, without being in direct contact with that enzyme.

Repression of [[DNA repair]] mechanisms

There are two main DNA-damage-signaling pathways that shelterin represses: the ATR kinase pathway, blocked by POT1, and the ATM kinase pathway, blocked by TRF2. In the ATR kinase pathway, ATR and ATRIP sense the presence of single-stranded DNA and induce a phosphorylation cascade that leads to cell cycle arrest. To prevent this signal, POT1 "shelters" the single-stranded region of telomeric DNA. The ATM kinase pathway, which starts from ATM and other proteins sensing double strand breaks, similarly ends with cell cycle arrest. TRF2 may also hide the ends of telomeres, just as POT1 hides the single-stranded regions. Another theory proposes the blocking of the signal downstream. This will lead to a dynamic instability of the cells over time.

TIN2 and TRF2 independently block accumulation of the DNA repair enzyme PARP1 at telomeres.

The structure of the T-loop may prevent NHEJ. For NHEJ to occur, the Ku heterodimer must be able to bind to the ends of the chromosome. Another theory offers the mechanism proposed earlier: TRF2 hides the ends of telomeres.

Species differences

At least four factors contribute to telomere maintenance in most eukaryotes: telomerase, shelterin, TERRA and the CST Complex. Fission yeast (Schizosaccharomyces pombe) has a shelterin complex for protection and maintenance of telomeres, but in budding yeast (Saccharomyces cerevisiae) this function is performed by the CST Complex. For fission yeast, Rap1 and Pot1 are conserved, but Tpz1 is an ortholog of TPP1 and Taz1 is an ortholog of TRF1 and TRF2.

Plants contain a variety of telomere-protecting proteins which can resemble either shelterin or the CST Complex.

The fruit fly Drosophila melanogaster lacks both shelterin and telomerase, but instead uses retrotransposons to maintain telomeres.

Non-telomeric functions of shelterin proteins

TIN2 can localize to mitochondria where it promotes glycolysis. TIN2 loss in human cancer cells has resulted in reduced glycolysis and increased oxidative phosphorylation.

RAP1 regulates transcription and affects NF-κB signaling.

References

References

1. (2010). "How Shelterin Solves the Telomere End-Protection Problem". [[Cold Spring Harbor Laboratory Press.
2. (2017). "Double-stranded telomeric DNA binding proteins: Diversity matters". [[Cell Cycle]].
3. "Telomeres do D-loop-T-loop". [[Cell (journal). Cell]]. (1999)
4. (2019). "Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction". [[Biogerontology (journal).
5. (2008). "A Novel Small Molecule That Alters Shelterin Integrity and Triggers a DNA-Damage Response at Telomeres". Journal of the American Chemical Society.
6. (2016). "The shelterin complex and hematopoiesis". [[Journal of Clinical Investigation]].
7. (2008). "How Shelterin Protects Mammalian Telomeres". Annual Review of Genetics.
8. (2008). "The telomere/shelterin complex and its functions". Genome Biology.
9. Titia de Lange. (2018). "Shelterin-Mediated Telomere Protection". [[Annual Review of Genetics]].
10. Diotti R, Loayza D. (2011). "Shelterin complex and associated factors at human telomeres". Nucleus.
11. Sfeir A. (2012). "Telomeres at a glance". [[Journal of Cell Science]].
12. (2015). "Shelterin proteins and cancer". [[Asian Pacific Journal of Cancer Prevention]].
13. (2013). "TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells". Nat Commun.
14. Bejarano L, Schuhmacher AJ, Méndez M, Megías D, Blanco-Aparicio C, Martínez S, Pastor J, Squatrito M, Blasco MA. (2017). "Inhibition of TRF1 Telomere Protein Impairs Tumor Initiation and Progression in Glioblastoma Mouse Models and Patient-Derived Xenografts". [[Cancer Cell (journal).
15. Derevyanko A, Whittemore K, Schneider RP, Jiménez V, Bosch F, Blasco MA. (2017). "Gene therapy with the TRF1 telomere gene rescues decreased TRF1 levels with aging and prolongs mouse health span". [[Aging Cell]].
16. Méndez-Pertuz M, Martínez P, Blanco-Aparicio C, Gómez-Casero E, Belen García A, Martínez-Torrecuadrada J, Palafox M, Cortés J, Serra V, Pastor J, Blasco MA. (2017). "Modulation of telomere protection by the PI3K/AKT pathway". [[Nature Communications]].
17. (2011). "Characterization of the DNA binding specificity of Shelterin complexes". Nucleic Acids Research.
18. (2018). "Current Perspectives of Telomerase Structure and Function in Eukaryotes with Emerging Views on Telomerase in Human Parasites". [[International Journal of Molecular Sciences]].
19. (2017). "Solving the Telomere Replication Problem". [[Genes (journal).
20. (2009). "Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall". [[Circulation (journal).
21. Nandakumar J1, Cech TR. (2013). "Finding the end: recruitment of telomerase to telomeres". [[Nature Reviews Molecular Cell Biology]].
22. (2018). "Heart-Breaking Telomeres". [[Circulation Research]].
23. Flynn RL, Zou L. (2010). "Oligonucleotide/oligosaccharide-binding fold proteins: a growing family of genome guardians". [[Critical Reviews in Biochemistry and Molecular Biology]].
24. Martínez P1, Blasco MA. (2010). "Role of shelterin in cancer and aging". [[Aging Cell]].
25. (June 2010). "TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo". Mol. Cell. Biol..
26. (2021). "Molecular mechanisms of telomere biology disorders". [[Journal of Biological Chemistry]].
27. "ACD ACD, shelterin complex subunit and telomerase recruitment factor [Homo sapiens (human)] - Gene - NCBI".
28. (2010). "In Vivo Stoichiometry of Shelterin Components". Journal of Biological Chemistry.
29. (2010). "CST meets shelterin to keep telomeres in check". [[Molecular Cell]].
30. (2010). "Evolution of CST function in telomere maintenance". [[Cell Cycle (journal).
31. (2014). "SUMOylation regulates telomere length by targeting the shelterin subunit Tpz1(Tpp1) to modulate shelterin-Stn1 interaction in fission yeast". [[Proceedings of the National Academy of Sciences of the United States of America.
32. (2016). "Telomere- and Telomerase-Associated Proteins and Their Functions in the Plant Cell". [[Frontiers Media.
33. (2011). "Retrotransposons that maintain chromosome ends". [[Proceedings of the National Academy of Sciences of the United States of America.
34. (2012). "Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control". [[Molecular Cell]].